• About us
• Contact

Advertisement

Product › Details

small-molecule cancer drug

	Next higher product group	cancer drug

Record changed: 2025-01-25

Advertisement

More documents for small-molecule cancer drug

• [1] Coulter Partners. (1/23/25). "Press Release: Coulter Partners Secures CEO Placement for NeoPhore"....
• [2] Eli Lilly and Company. (1/13/25). "Press Release: Lilly to Acquire Scorpion Therapeutics' Mutant-selective PI3Ka Inhibitor Program". Indianapolis, IN & Boston, MA....
• [3] NeoPhore Ltd.. (12/16/24). "Press Release: NeoPhore Appoints Michael Shih as Chief Executive Officer". London....
• [4] Tasca Therapeutics Corporation. (12/10/24). "Press Release: Tasca Therapeutics Launches with $52 Million Series A Financing to Develop Small Molecule Inhibitors for Multiple Oncology Indications". Boston, MA....
• [5] NextRNA Therapeutics, Inc.. (8/28/24). "Press Release: Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-coding RNAs (lncRNAs) in Oncology". Berlin & Boston, MA....
• [6] Boehringer Ingelheim. (7/29/24). "Press Release: Boehringer Ingelheim Secures Novel Immune Checkpoint Inhibitor with Acquisition of Nerio Therapeutics". Ingelheim & La Jolla, CA....
• [7] Merck KGaA. (6/24/24). "Press Release: Merck Provides Update on Xevinapant Program in Locally Advanced Head and Neck Cancer [ Not intended for UK-, US- or Canada-based media ]". Darmstadt....
• [8] NeoPhore Ltd.. (5/22/24). "Press Release: NeoPhore Closes Oversubscribed Series B Extension Round with Additional Funding from Bristol Myers Squibb". London....
• [9] Eisbach Bio GmbH. (5/6/24). "Press Release: Eisbach Bio Announces FDA Clearance of IND Application for EIS-12656, a First-in-Class Allosteric Inhibitor of ALC1". Martinsried....
• [10] Alterome Therapeutics, Inc.. (4/3/24). "Press Release: Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives". San Diego, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.